Global Glycated Hemoglobin Testing Market Analysis, Trends, Drivers, Challenges & Forecasts 2018-2022, With an Expected CAGR of 9.13% - ResearchAndMarkets.com

DUBLIN--()--The "Global Glycated Hemoglobin Testing Market 2018-2022" report has been added to ResearchAndMarkets.com's offering.

The analysts forecast the Global Glycated Hemoglobin Testing Market to grow at a CAGR of 9.13% during the period 2018-2022.

Glycated Hemoglobin Testing helps to determine the average blood glucose level of individuals two to three months prior to the test to understand whether diabetes is controlled.

One trend affecting this market is the increased adoption of automation in diabetes care. Fully automated solutions can save costs of staffing and generate precise results.

One driver influencing this market is the rising incidence of diabetes and related conditions. The growing prevalence of diabetes cater to the rise in the demand for diagnostic methods to detect diabetes.

The report states that one challenge affecting this market is the high cost of tests and reimbursement restrictions. Manufacturers may not be able to fully recover their expenses since most health insurance companies have limitations on reimbursements.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Companies Mentioned

  • Abbott
  • Bio-Rad Laboratories
  • Danaher
  • EKF Diagnostics
  • F. Hoffmann-La Roche

Key Topics Covered:

1: Executive Summary

2: Scope Of The Report

3: Research Methodology

4: Market Landscape

5: Market Sizing

6: Five Forces Analysis

7: Customer Landscape

8: Market Segmentation By End-User

9: Regional Landscape

10: Decision Framework

11: Drivers And Challenges

12: Market Trends

13: Vendor Landscape

14: Vendor Analysis

15: Appendix

For more information about this report visit https://www.researchandmarkets.com/research/gkj6zx/global_glycated?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Coagulation and Hemostasis Testing

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Coagulation and Hemostasis Testing